Fusiderm-B Cream is a topical medication combining Betamethasone (0.1% w/w), a potent corticosteroid, with Fusidic Acid (2% w/w), a bacteriostatic antibiotic, designed for the treatment of inflammatory skin conditions complicated by bacterial infections. Betamethasone works by reducing inflammation, redness, and itching through its anti-inflammatory and immunosuppressive properties, while Fusidic Acid targets and inhibits the growth of susceptible bacteria, particularly Staphylococcus species, by interfering with bacterial protein synthesis. This dual-action formulation is effective in managing conditions such as infected eczema, dermatitis, and other superficial bacterial skin infections where inflammation and bacterial colonization coexist. Fusiderm-B Cream should be applied in a thin layer to the affected area, typically two to three times daily, as directed by a healthcare professional. It is important to avoid prolonged use to minimize the risk of corticosteroid-related side effects such as skin thinning, and to use under medical supervision to prevent antibiotic resistance. The cream is for external use only and should not be applied to open wounds, eyes, or mucous membranes. Patients should inform their doctor of any allergies or pre-existing conditions before use. Fusiderm-B Cream offers an effective therapeutic option for combined inflammatory and bacterial skin disorders.